Leyser K H, Konietzke D, Hennes H J
Klinik für Anaesthesiologie der Johannes-Gutenberg-Universität Mainz.
Anaesthesist. 1989 Jun;38(6):288-93.
Clinical and electromyographic effects of either succinylcholine (Suc) or vecuronium bromide (VEC) were compared during induction and maintenance of neuromuscular blockade for pelvic laparoscopy.
Forty ASA class I and II patients (pat.) were studied under general anesthesia with thiopental, enflurane, and nitrous oxide. Group VEC-pat. (n = 20) received 0.015 mg/kg body wt. VEC as priming and 5 min later 0.085 mg/kg as intubation doses. Repetitive doses of 0.01 mg/kg were injected to maintain twitch depression (T1%) less than or equal to 15%. Neuromuscular block was reversed with atropine and pyridostigmine (0.01 resp. 0.1 mg/kg). In group Suc-pat. relaxation was induced with 1.5 mg/kg Suc 5 min after pretreatment with 2 mg alcuronium. Relaxation (10% less than or equal to T1% less than or equal to 15%) was prolonged using a Suc infusion. Neuromuscular blockade was assessed electromyographically (Relaxograph, Datex) using train-of-four (TOF) stimulation (2 Hz for 2 s). Intubation conditions were scored according to Fahey et al.
Pretreatment with 0.015 mg/kg VEC compared to 2 mg alcuronium led to a more pronounced decline in T1% and TOF-ratio (P less than 0.001). The time interval between injection of the intubation dose and complete relaxation (T1% less than or equal to 5%) was shorter in group Suc- than in VEC-pat. (P less than 0.001). Suc provides better intubation conditions than VEC (P less than 0.05). Recovery from muscle relaxation was faster in Suc- than in VEC-pat. (P less than 0.001). During Suc infusion in 8 patients a phase-II block (TOF ratio less than or equal to 30%) was observed.
Postoperative problems are often related to an unrecognized after effects of relaxants. Suc infusion leads to a remarkable number of phase-II blocks, whereas VEC can be antagonized promptly.
在盆腔腹腔镜检查的神经肌肉阻滞诱导和维持过程中,比较了琥珀酰胆碱(Suc)或溴化维库溴铵(VEC)的临床和肌电图效应。
40例ASA I级和II级患者在硫喷妥钠、恩氟烷和氧化亚氮全身麻醉下进行研究。VEC组患者(n = 20)静脉注射0.015 mg/kg体重的VEC作为预充量,5分钟后注射0.085 mg/kg作为插管剂量。重复注射0.01 mg/kg以维持颤搐抑制(T1%)小于或等于15%。用阿托品和新斯的明(分别为0.01和0.1 mg/kg)逆转神经肌肉阻滞。在Suc组患者中,在预先给予2 mg阿库氯铵5分钟后,静脉注射1.5 mg/kg Suc诱导肌肉松弛。通过输注Suc延长肌肉松弛时间(10%≤T1%≤15%)。使用四个成串刺激(TOF)(2 Hz,持续2秒)通过肌电图(Relaxograph,Datex)评估神经肌肉阻滞。根据Fahey等人的方法对插管条件进行评分。
与2 mg阿库氯铵相比,0.015 mg/kg VEC预充后T1%和TOF比率下降更明显(P < 0.001)。Suc组患者从注射插管剂量到完全松弛(T1%≤5%)的时间间隔比VEC组短(P < 0.001)。Suc提供的插管条件优于VEC(P < 0.05)。Suc组患者肌肉松弛恢复比VEC组快(P < 0.001)。在8例患者输注Suc期间,观察到II期阻滞(TOF比率≤30%)。
术后问题通常与未被识别的肌松药后遗症有关。输注Suc会导致相当数量的II期阻滞,而VEC可以迅速被拮抗。